# Probiotics Digestive Symptoms Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/probiotics-digestive-symptoms-meta-analysis-evidence-review
Category: evidence-review
Summary: Probiotics Digestive Symptoms Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass
Last reviewed: 2026-07-05
Reviewed by: Migaku Evidence Review
# Probiotics Digestive Symptoms Meta-analysis: What the Evidence Says

## Quick Answer

Probiotics Digestive Symptoms Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are guideline, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 guideline, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Clinical Guidance and Practical Recommendations for Probiotic Use in Patients With Irritable Bowel Syndrome, Functional Constipation, and Clostridioides difficile Infection Considering Sex-based Differences | guideline | 2 | 2026-04-30 | 10.5056/jnm25221 |
| Cluster analysis of research hotspots and trends in probiotics for constipation: A comprehensive bibliometric analysis (1977–2024) | research article | 4 | 2026-05-01 | 10.1097/MD.0000000000048338 |

## What The Sources Report

- This review summarizes the current concepts of probiotics and evaluates evidence supporting their use in patients with lower GI disorders, with a focus on potential sex-related differences. [Kim Yong Sung (2026); evidence level 2]
- Saccharomyces, Lactobacillus Bifidobacterium Clostridium difficile 7 This review was conducted to summarize and interpret the current evidence on probiotics on IBS, FC, and CDI in terms of sex differences. [Kim Yong Sung (2026); evidence level 2]
- This bibliometric analysis was conducted and reported in accordance with the Guideline for Reporting Bibliometric Reviews of the Biomedical Literature (BIBLIO). [Shen Yirong (2026); evidence level 4]
- Frequently occurring terms like "prevalence," "adults," "children," "health," "risk," and "prevention" emphasize efforts to map the distribution of constipation, identify at-risk populations, and develop preventive strategies at the public health level. [Shen Yirong (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For probiotics digestive symptoms meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Kim Yong Sung (2026). Clinical Guidance and Practical Recommendations for Probiotic Use in Patients With Irritable Bowel Syndrome, Functional Constipation, and Clostridioides difficile Infection Considering Sex-based Differences. DOI: 10.5056/jnm25221. PMCID: PMC13071424. PMID: 41807013. License: https://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0 This is an open-access .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13071424/
- Shen Yirong (2026). Cluster analysis of research hotspots and trends in probiotics for constipation: A comprehensive bibliometric analysis (1977–2024). DOI: 10.1097/MD.0000000000048338. PMCID: PMC13138477. PMID: 42065212. License: https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) Thi.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13138477/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.